Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,356,139 papers from all fields of science
Search
Sign In
Create Free Account
Package Inserts
Known as:
Insert, Package
, Inserts, Package
, Package Insert
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Pharmaceutical Product Label
ingredient labeling
product label
warning labels
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Analysis of safety‐related regulatory actions by Japan's pharmaceutical regulatory agency
Chieko Ishiguro
,
T. Misu
,
Eiko Iwasa
,
Tadashi Izawa
Pharmacoepidemiology and Drug Safety
2017
Corpus ID: 24718861
To evaluate the safety‐related regulatory actions implemented by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) in…
Expand
Review
2016
Review
2016
Factors influencing subjects’ comprehension of a set of medicine package inserts
Carla Pires
,
Marina Vigário
,
A. Cavaco
International Journal of Clinical Pharmacy
2016
Corpus ID: 24345575
Background Package inserts (PIs) should promote the safe and effective use of medicines. The comprehension of PIs is related to…
Expand
Review
2013
Review
2013
Imiquimod, Molluscum, and the Need for a Better “Best Pharmaceuticals for Children” Act
K. Katz
,
Glenda L. Swetman
Pediatrics
2013
Corpus ID: 29556501
* Abbreviations: BPCA — : Best Pharmaceuticals for Children Act FDA — : Food and Drug Administration MC — : Molluscum…
Expand
2010
2010
Excessive medical information increase in package inserts.
J. Fuchs
,
S. Werner
,
+7 authors
M. Hippius
International journal of clinical pharmacology…
2010
Corpus ID: 35291301
OBJECTIVES Package inserts are the most frequent source of patient information about medicines aside from doctors and pharmacists…
Expand
Review
2010
Review
2010
The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
Ajay K. Singh
American Society of Nephrology. Clinical Journal
2010
Corpus ID: 29608004
The Trial to Reduce Cardiovascular Endpoints with Aranesp Therapy (TREAT) (1) has prompted the Food and Drug Administration (FDA…
Expand
2006
2006
How important is a package insert for drug therapy in ambulatory care?
C. Stahl
,
S. Brauer
,
H. Zeitler
,
M. Gulich
Journal of public health
2006
Corpus ID: 21019256
German regulations demand an extensive package insert for drugs. However, to what extent the information given is used and what…
Expand
Review
2003
Review
2003
Public Attitude toward Drug Technical Package Inserts in Saudi Arabia
S. Bawazir
,
H. Abou-Auda
,
Othman A. Gubara
,
K. Al‐Khamis
,
M. Al-Yamani
2003
Corpus ID: 73307377
Objective: To examine public opinion in Saudi Arabia regarding the technical drug package insert (PI) as a source of information…
Expand
1989
1989
Patient Package Inserts: The Belgian Experience with a Mandatory Program
R. V. Stichele
,
M. Bogaert
1989
Corpus ID: 72901373
The health authorities of Belgium, a European country with a population of 10 million and 3 national languages, decided in 1984…
Expand
1984
1984
Attitudes of private medical practitioners towards package inserts and other drug information sources.
Joubert Ph
,
D. Skene
South African medical journal = Suid-Afrikaanse…
1984
Corpus ID: 32795502
One thousand questionnaires were distributed to private medical practitioners by representatives of a pharmaceutical company. The…
Expand
1975
1975
The Patient Package Insert
F. Mcmahon
1975
Corpus ID: 77907401
The Food and Drug Administration (FDA), as the government regulatory agency responsible for labeling prescription drugs for safe…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE